GEHC Stock Analysis: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$74.82
0.76 (1.03%)
▲
5d:
+1.53%
30d:
+20.7%
90d:
+16.31%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 17, 2026 at $72.31 · last confirmed Aug 21, 2026
Strength: 4.6/10
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GEHC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GEHC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$102.62
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$63.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $74.82, which is considered extended relative to its 30-day fair value range of $63.45 to $73.16. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (13.6). At these levels, the market is pricing in 0.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GEHC is in a uptrend. The price is approaching resistance at $75.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GEHC scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.50 (+10.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GEHC is in a uptrend. The price is approaching resistance at $75.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GEHC scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.50 (+10.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$63.45 -
$73.16
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding GEHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($82.50)
- NEUTRAL: Market pricing in 0.5% annual earnings growth - fairly valued
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$63.45 -
$73.16
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$71.01
Resistance Level
$75.65
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.83
Wall Street Target
$82.50
(+10.3%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
16.8%
Profit Margin
9.3%
Valuation Premium vs History
+0.5% premium
PE vs Historical
13.8 vs 13.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.5%
(market-implied from PE analysis)
1-Year Target
$75.19
(+1%)
2-Year Target
$75.57
(+1%)
3-Year Target
$75.95
(+2%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
PE COMPRESSION
$74.69
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 9.8%)
$143.72
(+92%)
Base:
(SPY PE: 13.8, Growth: 9.8%)
$99.03
(+32%)
Bear:
(PE: 11.8, Growth: 9.8%)
$84.18
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 17.06 | Current EPS (TTM): $4.34
Bull Case
$101.55
(+36%)
Analyst growth 24.7%, PE expands to 18.8
Base Case
$92.32
(+23%)
Market implied 24.7%, PE stable at 17.1
Bear Case
$50.36
(-33%)
Severe decline -20.0%, PE contracts to 14.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 9:34 PM ET
Data refreshes hourly during market hours. Next update: 10:34 PM
Data refreshes hourly during market hours. Next update: 10:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Terri A. Sewell
SELL
2026-03-25
Warren Davidson
SELL
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
